Form 4: Dentsply Sirona Director Boosts Equity Holdings

Dentsply Sirona Director Jonathan Jay Mazelsky increased his beneficial ownership of common stock and phantom stock through dividend reinvestments.

Summary

• Director Jonathan Jay Mazelsky acquired additional equity in DENTSPLY SIRONA Inc. on January 9, 2026.
• Acquired 395.158 shares of Common Stock through dividends on restricted stock units (RSUs). These RSUs were acquired at a price of $0 and are subject to the same vesting terms as the underlying awards.
• Acquired 153.7009 shares of Phantom Stock as a result of accrued dividends, with an acquisition price of $12.22 per share.
• Following these transactions, Mazelsky beneficially owns 28,846.534 shares of Common Stock and 14,535.2138 shares of Phantom Stock directly.
• The phantom stock is the economic equivalent of common stock and becomes payable upon termination of service as a director.

Sentiment

Score: 7

Explanation: The filing indicates a director's increased equity stake through dividend reinvestment, which is generally a positive sign of alignment with shareholder interests, though it's a routine compensation event rather than an open market purchase.

Positives

• Director Jonathan Jay Mazelsky increased his beneficial ownership in the company, indicating continued alignment with shareholder interests.
• The acquisitions were through dividend reinvestments, suggesting a standard compensation or deferred compensation plan.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends for the dental products and technologies sector. It reflects standard compensation practices for directors.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Increased director ownership may be viewed positively as it aligns the director's interests with those of shareholders.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director through dividend reinvestment on existing compensation awards. While it shows continued alignment of interests, it does not represent a significant new investment decision or provide new fundamental information to warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

DENTSPLY SIRONA, XRAY, Jonathan Jay Mazelsky, Director, Insider Trading, Form 4, Equity Acquisition, Restricted Stock Units, Phantom Stock, Dividend Reinvestment, Corporate Governance